ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate0.160.421.481.83
Low Estimate-0.140.391.171.6
High Estimate0.260.441.62.12
Year Ago EPS0.370.761.961.48
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate24.34M29.36M118.87M126.18M
Low Estimate24.01M29.01M118.58M121.05M
High Estimate24.68M29.9M119.1M130.4M
Year Ago Sales23.39M33.46M113.42M118.87M
Sales Growth (year/est)4.10%-12.30%4.80%6.10%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.0.380.440.450.44
EPS Actual0.370.760.460.38
Difference-0.010.320.01-0.06
Surprise %-2.60%72.70%2.20%-13.60%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0.160.421.481.83
7 Days Ago0.160.421.481.83
30 Days Ago0.250.421.581.88
60 Days Ago0.320.51.822.01
90 Days Ago0.320.511.831.85
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesANIKIndustrySectorS&P 500
Current Qtr.-56.80%N/AN/A0.42
Next Qtr.-44.70%N/AN/A0.38
Current Year-24.50%N/AN/A0.20
Next Year23.60%N/AN/A0.10
Next 5 Years (per annum)10.00%N/AN/A0.12
Past 5 Years (per annum)6.92%N/AN/AN/A